Literature DB >> 3584444

Preoperative Russell traction in Legg-Calvé-Perthes disease.

W Serlo, E Heikkinen, J Puranen.   

Abstract

Divergent opinions about the pathophysiology and the optimal time and methods for the treatment of Legg-Calvé-Perthes (LCP) disease exist. Synovitis causing restriction of hip motions may be hazardous to the circulation to the femoral head. We studied 23 children (24 hips) in the initial phase of LCP disease. Seven to 14 days of Russell traction decreased the intraosseous pressure significantly (p less than 0.001) and increased the hip motion a mean of 33.6 degrees. As assessed by osteovenography, the venous congestion decreased in almost every hip during Russell traction.

Entities:  

Mesh:

Year:  1987        PMID: 3584444     DOI: 10.1097/01241398-198705000-00008

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  5 in total

1.  [Current treatment strategies in Legg-Calvé-Perthes disease].

Authors:  B Westhoff; F Martiny; R Krauspe
Journal:  Orthopade       Date:  2013-12       Impact factor: 1.087

2.  Ultrasonography in Perthes' disease. Clinical relevance and influence on treatment.

Authors:  T Wirth; G W LeQuesne; D C Paterson
Journal:  Int Orthop       Date:  1993-11       Impact factor: 3.075

3.  Legg-Calvé-Perthes disease: role of isolated adductor tenotomy?

Authors:  Joaquín Moya-Angeler; Juan Carlos Abril; Ignacio Varo Rodriguez
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-10-30

4.  Treatment outcome in the most severely affected Legg-Perthes patients, comparing prolonged traction in abduction with femoral varus derotation treatment.

Authors:  F B M Wagenaar; C G B Maathuis; R H G P van Erve
Journal:  J Child Orthop       Date:  2010-12-14       Impact factor: 1.548

5.  Hip range of motion in Perthes' disease: comparison of pre-operative and intra-operative values.

Authors:  Carl L Stanitski
Journal:  J Child Orthop       Date:  2007-03-03       Impact factor: 1.548

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.